The article discusses the use of radium Ra 223 dichloride therapy in private medical practice. It notes that Ra is an isotope of radium that has an 11.4 day half-life and decays primarily via four α emissions in addition to β and photon emissions. It cites the need for a written directive from, and must be performed under the supervision of an authorized user when administering radium Ra 223 dichloride.